Skip to main content
Download PDF

Lactobacillus reuteri improves the development and maturation of fecal microbiota in piglets through mother-to-infant microbe and metabolite vertical transmission

Microbiome volume 10, Article number: 211 (2022) Cite this article

Abstract

Background

The immature neonatal fecal microbiota substantially impacts the development of gut health and greatly increases the risk of disease. Developing effective strategies to modulate the development of neonatal fecal microbiota has great significance. Herein, we investigated whether the maternal dietary supplementation and oral administration of Lactobacillus reuteri could effectively promote the development and maturation of the fecal microbiome in piglets from birth to weaning.

Results

Metagenomic analysis of colostrum showed that maternal dietary L. reuteri supplementation influenced the overall microbiota composition, decreased the abundance of the phylum Proteobacteria and increased that of the species Bifidobacterium choerinum. KEGG pathway analysis revealed that maternal L. reuteri supplementation enriched the lysine biosynthesis and glycolysis/gluconeogenesis pathways and downregulated the bacterial invasion of epithelial cells in the colostrum. In addition, L. reuteri supplementation significantly altered the metabolite features and modules in umbilical cord blood serum based on metabolomics. Further, a significant covariation was observed between these differential metabolites and the species in colostrum. Maternal dietary L. reuteri supplementation also significantly influenced the microbiota composition and increased the meconium abundance of beneficial bacteria (such as Romboutsia, Lactobacillus, Blautia, Butyricicoccus, and Ruminococcus), some of which were markedly associated with several differential metabolites in umbilical cord blood serum between two groups. Notably, both the maternal dietary supplementation and oral intake of L. reuteri had strong impacts on the overall microbial composition and maturation of fecal microbiota in piglets during early life, and these effects were dependent on the growth stage. Oral administration of L. reuteri promoted diarrhea resistance in neonates, while maternal supplementation of L. reuteri enhanced the abilities of antioxidants and decreased inflammation. Moreover, the administration of L. reuteri via both methods in combination improved the growth performances of piglets.

Conclusion

Overall, our data demonstrated that L. reuteri had the ability to modulate the composition of fecal microbiota in newborn piglets by influencing the microbial community and functional composition in the colostrum and by altering several key metabolites in the umbilical cord blood serum. Also, both the maternal dietary supplementation and oral administration of L. reuteri effectively promoted the development and maturation of the fecal microbiome in piglets during early life. Both the maternal dietary supplementation and oral administration of L. reuteri in combination optimized the growth performances of piglets.

Video Abstract

Background

The mucosal surface of the mammalian gastrointestinal tract interfaces with a dense and diverse community of microbes, which have been recognized as critical regulators of host physiology and immune homeostasis [1]. In early life, the immune system and intestinal function of newborns are immature, which greatly increases the risk of disease. Infants can receive specific signals from microbes in critical time windows during early development. These microbial signals stimulate the development of the immune system and potentially decrease disease susceptibility [2]. In contrast to its stability and maturity in adults, the microbiota in neonates is less stable and is variable. Increasing evidence has revealed that a dysfunctional early-life microbiota is associated with health outcomes later in life, such as asthma, allergies, obesity, and neuropsychiatric disorders [3,4,5,6]. Germ-free mice receiving intestinal microbiota from only neonatal donors contributes significantly to the long-term development of innate and adaptive immunity [7].

The early colonization and maturation of the natural intestinal microbiota are influenced by intrinsic [8] and extrinsic factors [9, 10]. Multiple studies have indicated that oral administration of the commensal infant microbiota via probiotic supplementation is an effective means to improve the early-life dysfunctional microbiota, as observed in human [11] and animal studies [12]. Two double-blinded placebo-controlled randomized clinical trials indicated that postnatal administration of a probiotic mixture to infants could improve microbiota composition and function [13, 14]. The underlying mechanisms of probiotics are hypothesized to be improvement of epithelial barrier function [15], modulation of microbiota composition [16], induction of immunomodulation [17], and suppression of pathogens [18]. In addition to direct regulation of the infant microbiota, maternal factors also influence postnatal early microbiota development. However, infants are sterile at birth, or prenatal colonization by the microbiota remains debated [19, 20]. What is clear is that extensive transfer of the maternal microbiota to the infant could occur during vaginal delivery and breastfeeding, as well as maternal feces [21, 22], resulting in initiation of colonization. The status of the maternal microbiota under the influence of external factors such as diet [23] and infection [24] during pregnancy negatively or positively affects the microbiota in the offspring intestine after birth. Thus, the infant’s intestinal microbiota could be improved by modulating the maternal microbiota that will be transferred to the offspring.

Investigations on the modulation of the development of the infant gut microbiota have mainly focused on the maternal diet [23], feeding style [25], and administered antibiotics [9]. To date, several studies have investigated the relationship of probiotics with the development of gut microbiota in infants [26,27,28,29]. However, whether the effect of the probiotic on the mother could modulate the development of infant microbiota through the umbilical cord blood before birth or the milk after birth and whether there is an additive effect of the combination of maternal probiotic supplementation and neonatal oral probiotic administration remain to be determined.

Lactobacillus reuteri is a commensal intestinal species that resides in the gastrointestinal tracts of humans and animals [30]. A double-blinded placebo-controlled trial revealed that daily administration of L. reuteri to preterm infants modulated the fecal microbiota composition and increased bacterial diversity. Another report also showed that L. reuteri promoted the development of the intestinal mucosal system in newborn piglets [31]. L. reuteri I5007 (NCBI ID: 1340495) was isolated from the colonic mucosa of healthy weaning piglets in our previous study [32] and was indicated to have several probiotic properties [16, 33, 34]. Pigs are similar to humans in some features, such as microbiology, diet, and genetics and have been used as an animal model in biomedical research [35, 36]. In contrast to rodents, the sow-piglet dyad is a more promising model for the human mother-infant dyad to study the development of intestinal immune systems and the mature of intestinal microbiota during the early postnatal stage of life [37, 38]. Thus, this study aimed to investigate the effect of maternal dietary L. reuteri I5007 supplementation on the compositional changes in intestinal and colostrum microbiota in sows and in the fecal microbiota of piglets from birth to weaning. The alteration of metabolite features in the umbilical cord blood serum was also investigated. Our results revealed that L. reuteri, administered directly or indirectly via vertical transfer, improved the development and maturation of fecal microbiota and subsequently promoted the early growth of piglets.

Methods

Experimental design and sample collection

Twenty-six healthy sows in late gestation were chosen in this study. The sows were randomly allocated into two groups: control treatment (n=13), in which sows were fed the pregnancy diet; I5007 treatment (n=13), in which sows were fed the pregnancy diet supplemented with L. reuteri I5007 (109 colony-forming units (CFU)/kg diet). The lactation diet fed to the two groups was the same as the pregnancy diet but was not supplemented with L. reuteri I5007. After delivery, the number of newborn piglets in each litter per sow was adjusted to six. The piglets were further divided into two treatment groups: oral or nonoral administration of L. reuteri in the different sow groups (detail see Fig. 1). Eventually, four groups were generated as follows: (1) Control_Oral group, the piglets from the control group sows with oral administration of L. reuteri I5007 (5 mL, 109 CFU/mL); (2) Control_Nonoral group, the piglets from the control group sows with oral administration of sterile saline (5 mL); (3) I5007_Oral group, the piglets from the I5007 group sows with oral administration of L. reuteri I5007 (5 mL, 109 CFU/mL); (4) I5007_Nonoral group, the piglets from the I5007 group sows with oral administration of sterile saline (5 mL). After weaning, all piglets remained in nursing pens (six piglets per pen) for another week until day 28. The diet of sows during pregnancy and lactation and the diet of piglets during the suckling period and 1 week after weaning all met the NRC (2012) nutritional requirements.

Fig. 1
figure 1

Experimental design and workflow of sample collection. Healthy crossbred sows (Landrace and Yorkshire, n=26) in the late gestation stage with similar expected delivery dates were chosen in this study. The sows were randomly allocated into groups with or without the addition of L. reuteri I5007 via the diet. The period of treatment in sows was 28 days. After parturition, the piglets from the two groups of sows were divided into two treatments: oral administration of L. reuteri I5007 or saline. At day 14 after birth, the piglets were offered creep feed ad libitum and had free access to water. The piglets were kept with the sow until weaning at day 21. The period of treatment in piglets was 21 days. Stool samples of sows and piglets were collected by swabbing. The day when the treatment started was counted as day 0. The figure was created by BioRender.com (https://app.biorender.com/)

Full size image

The rectal swabs of sows were collected on days 0, 7, 14, and 21 during pregnancy, the day of delivery, and days 3, 7, and 14 during lactation. The rectal swab was performed by inserting sterile swab approximately 1–1.5 cm in the anal canal, moving swab from side to side in the anal canal and allowing swab to remain 10–30 s for absorption of microbes onto the swab. After sampling, the swabs were submerged into DNA protection solution and subsequently stored in liquid nitrogen. Umbilical cord blood samples were collected on the day of delivery. The colostrum was collected from each sow within 6 h after delivery. Milk was collected on days 3, 7, and 14 after delivery. To exclude the influence of differences among litters, four litters were randomly selected from each group, and three piglets from each litter were selected for the collection of rectal swabs. Rectal swabs were collected from the piglets from birth to 28 days (days 0, 3, 7, 14, 21, and 28), and blood samples were collected from the piglets on day 21. The serum and colostrum samples were stored at −20 °C, and the rectal swabs were stored in liquid nitrogen after sampling. The body weight of the piglets was recorded on the indicated days to calculate the body weight gain, and the body weight data from piglets from the same litter were averaged to represent the body weight of the litter. The rectal swabs of independent piglets were collected within 1 week of weaning (from days 21 to 28). The fecal samples were from piglets with diarrhea (n=16) and from healthy (n=16) piglets.

Preparation of bacteria

L. reuteri I5007 was cultured in de Man, Rogosa, and Sharpe (MRS; Solarbio Science and Technology Co. Ltd., Beijing, China) medium at 37 °C for 20 h under anaerobic conditions and then centrifuged at 5000×g for 10 min at 4 °C. The pellet was resuspended in reconstituted skim milk (20% w/v) and immediately freeze-dried. The freeze-dried powder containing 1012 CFU/g was stored in sealed packets at 4 °C until use. The strain was requantified prior to use. For gavage, L. reuteri adjusted to a density of 109 CFU/mL with sterile saline.

DNA extraction, 16S rRNA gene sequencing, and data analysis

Total microbial DNA was extracted from 440 rectal swabs using the QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The extracted DNA was quantified using a NanoDrop (Thermo Fisher Scientific, Wilmington, DE, USA). The V3-V4 hypervariable regions of the 16S rRNA genes were amplified using the universal primers 338F (5′-GTGCCAGCMGCCGCGG-3′) and 806R (5′-CCGTCAATTCMTTTRAGTTT-3′). The optimized conditions for PCR amplification were as follows: initial denaturation for 3 min at 95 °C; 27 cycles of 30 s at 95 °C, 30 s at 55 °C, and 45 s at 72 °C; and a final elongation step for 10 min at 72 °C [39]. Two-percent agarose gel electrophoresis was performed to confirm the size of the PCR products. Then, the amplicons were quantified, pooled, and sequenced using the Illumina MiSeq system (Illumina Inc., San Diego, CA, USA) for paired-end reads. Sequence analysis was performed using the UNOISE pipeline through USEARCH v10.0 [40] and VSEARCH v2.15 [41]. Briefly, paired-end sequences were merged, quality filtered, and dereplicated using VSEARCH; denoising and chimera removal were then conducted using UNOISE3 to correct for sequencing errors. Assembled sequences were mapped back to the denoised chimera-free sequences as OTUs with 97% identity. The taxonomy of the features was classified by the USEARCH SINTAX algorithm in RDP training version 16 (http://rdp.cme.msu.edu/) [42]. The average V3-V4 16S rRNA gene sequencing depth was 43,559 ±7824 reads. The sequences of all the samples were downsized to 27,226 to match the difference in sequencing depth. α-diversity was measured from the rarefied OTU table by the richness, Simpson, and Shannon indices. β-diversity was estimated by Bray–Curtis distance, which were applied to build distance matrices and reported according to principal coordinate analysis (PCoA). For differential abundance analysis and association analysis, the taxa with relative abundance <0.01% and present in <20% across all samples were removed.

DNA extraction, metagenomic sequencing, and data analysis

Total microbial genomic DNA was extracted from 16 colostrum samples (1 mL) using the Milk DNA Extraction Kit (Norgen, Thorold, Ontario, Canada) following the manufacturer’s instructions. The quantity and quality of the extracted DNA were measured using a NanoDrop (Thermo Fisher Scientific, Wilmington, DE, USA) and agarose gel electrophoresis, respectively. The extracted microbial DNA was processed to construct metagenome shotgun sequencing libraries with insert sizes of 400 bp by using the Illumina TruSeq Nano DNA LT Library Preparation Kit.

The raw sequencing reads were first quality-controlled by Trimmomatic [43], and the clean reads were then aligned to the pig (Sus scrofa) genome with Bowtie2 [44] to exclude host contamination. Quality-filtered metagenomic reads were taxonomically profiled using Kraken2 [45]. High-quality reads were de novo assembled into contigs using MEGAHIT [46], generating a total of 364,772 contigs with an N50 length of 878 bp. The genes were annotated using Prokka (v.1.13.3) [47]. Then, the metagenomic contigs of all the samples were clustered by CD-HIT (v 4.5.8) [48] to obtain unigenes, and the abundance of unigenes in each sample was estimated by calculating the TPM value based on the number of aligned reads using Salmon (v 0.9.1) [49]. To identify metagenomic functional categories, the protein sequences were annotated against those of evolutionarily conserved genes in the nonsupervised orthologous groups (eggNOG) and CAZy databases using DIAMOND (v.0.8.23) [50] with default parameters. Statistically significant differences in taxa and functions across groups were determined by linear discriminant analysis (LDA) effect size (LEfSe) with the default parameters [51]. An LDA score >2.0 and p<0.05 were used as the thresholds for significant differences in the taxa and functions.

Untargeted metabolomic study

Metabolite concentrations in umbilical cord blood serum were quantified using UPLC-TOF-MS in both positive and negative ionization modes. Twenty microliters of a sample was extracted with 120 μL of cold methanol/acetonitrile (1:1, v/v) and vortexed for 1 min. The mixture was homogenized for 5 min and subsequently centrifuged at 14,000×g for 15 min at 4 °C. In addition, pooled QC samples were also prepared by combining 10 μL of each extraction mixture. Metabolite profiling was performed by using the procedures described previously [52].

The acquired data pretreatments included the retention time, m/z, and peak area of each sample. Each ion was identified based on the retention time and the m/z data pairs. Then, we obtained the intensities of each peak and a matrix including arbitrarily assigned peak indices (retention time-m/z pairs), sample names (observations), and ion intensity information (variables). The matrix was further reduced by removing peak data with missing values in more than 80% of the biological samples or 50% of the QC samples. After normalization to the total peak intensity, the processed data were uploaded into MetaboAnalyst software for further analysis (www.metaboanalyst.ca). Orthogonal projection to latent structure discriminant analysis (OPLS-DA) was performed to discriminate among the different metabolites between groups. Only metabolites with variable importance in the projection (VIP) greater than 1.0 were further analyzed using Student’s t test at the univariate level with adjusted P < 0.05.

Clustering of coabundant metabolites

Clustering of coabundant metabolites was performed using the R package weighted correlation network analysis (WGCNA) [53] based on correlation. The correlation matrix quantified interconnectedness between metabolites and assigned them to coabundance modules. The metabolites that did not show high enough coexpression metrics with any module were removed. The signed network was derived based on a biweight midcorrelation (bicor) method. A scale-free topology criterion was used to choose the soft threshold of eight for metabolite correlations. The minimum module size was five.

Determination of SCFA concentrations

The concentrations of short-chain fatty acids (SCFAs), including formic, acetic, propionic, butyric and lactic acid, in sow milk, and umbilical cord blood serum, were determined as previously described with slight modifications [54]. Briefly, 100 μL of milk or serum was added to 400 μL of methanol/acetonitrile (1:1, v/v) for protein precipitation, and the mixture was vortexed for 2 min and kept at room temperature for 10 min. The samples were then centrifuged at 12,000 rpm and 4 °C for 20 min, and the supernatant was transferred into an Eppendorf tube. The supernatant was then diluted with ultrapure water, vortexed for 1 min, and filtered through a 0.22-μm filter. The SCFA samples were placed in a 2-ml screw-cap vial and identified by high-performance ion chromatography (ICS-3000; Dionex, Sunnyvale, CA, USA) with a conductivity detector. Finally, the concentrations of the SCFAs were calculated from the peak areas of the compounds relative to the internal standards.

Interspecies correlations in each group

The species that showed differences in abundance (LEfSe: P<0.05, LDA>2) between the two groups across all colostrum samples were considered key species. Then, the sparse correlations among the key species were determined in the SparCC [55] python module with a bootstrap repeated 100 times. Co-occurrence network properties were analyzed with the R package igraph [56]. Only the correlation scores with absolute values greater than 0.7 and P values less than 0.05 were visualized by Cytoscape (v 3.7.1). To describe the topology of the network, several parameters (e.g., node number, edge number, clustering coefficient, average path length, average degree, graph density, betweenness centrality, degree centrality) were calculated [57]. We assessed the difference between species networks by bootstrapping node attributes (node degree, closeness centrality, betweenness centrality, and transitivity centrality) using a two-sample Kolmogorov–Smirnov test (bootstrap n=10,000). The Kolmogorov–Smirnov test compares the overall shape of the cumulative distribution of two variables, where the null hypothesis is that the variables have the same distribution patterns [58].

Determination of microbiota maturity using random forest

Age-specific taxa were identified with distinctive time-dependent changes in their relative abundances, and then, a random forest machine learning algorithm was used to regress the OTUs in the time-series profiles of the fecal microbiota against their chronologic age using default parameters of the R package randomForest [59]. Since the random forest algorithm has nonparametric assumptions, it was applied to detect both linear and nonlinear relationships between OTUs and chronological age, thereby identifying taxa that were highly correlated with periods of postnatal gut microbiota development. The random forest model was then applied to test the OTUs in the L. reuteri group. For the training of the random forest model, a smoothing spline function was fitted between microbiota age and chronological age of the control group. Based on the model, relative microbiota maturity was used to define the maturation of the fecal microbiota. The metrics were calculated as described previously [60]. The differences in microbiota maturation metrics among chronologic ages in the two groups were analyzed using the Wilcoxon rank-sum test.

Coinertia analysis (CIA) between the microbiota and metabolite data sets

Coinertia analysis is a method for ordination of the costructure between two data sets depending on their linear combinations. Additionally, CIA is coupled with principal component analysis or correspondence analysis. In the case of CIA, the coinertia between two data sets is maximized and decomposed. In this study, we used CIA to identify the relationship between the microbiota and serum metabolite data sets using the R package ade4 [61]. Two independent PCoAs were conducted based on the microbiota composition and serum metabolites using the relative abundance and Bray–Curtis distance and then subjected to coinertia analysis. The overall similarity between two data sets was then measured by the regression vector (RV) coefficient [61]. A Monte Carlo test was used to measure the significant association between two data sets.

Weight gain, diarrhea incidence, inflammatory cytokines, and antioxidant index

Piglets were weighted on days 0, 7, 14, 21, and 28. The average daily gain (ADG) was calculated on a litter basis. To evaluate the incidence of diarrhea, the fecal consistency of piglets was visually assessed three times per day during the experimental period by fixed observers blinded to the treatment according to the method described previously [62]. The diarrhea incidence was calculated as follows: diarrhea incidence (%) = (number of piglets with diarrhea) / (number of piglets × total observational days) × 100. The levels of interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), and malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) in the serum were measured using the corresponding commercial kits (CUSABIO, https://www.cusabio.com/) according to the manufacturer’s protocol.

Diarrhea classification based on fecal microbiota profiles by a support vector machine (SVM)

The health condition of each piglet was evaluated daily over the 28-day experimental period. Since diarrhea may cause temporal changes in the diversity and stability of the fecal microbiota and last several days, we only collected samples at the indicated times. If diarrhea occurred at a nonsampling time point and was continuous for 2 days, the sample was assigned to the next sampling point. For example, if a piglet exhibited diarrhea on days 15 and 16, the sample from the piglet was classified as “diarrhea” on day 21. To determine whether properties of the fecal microbiota could be used as biomarkers to distinguish between healthy and diarrheic animals, we built a machine learning model by SVM as previously described [63]. To establish the SVM model for predicting diarrhea, the minimal redundancy maximal relevance (mRMR) method and leave-one-out cross-validation (LOOCV) were applied. The OTU set with the highest Matthews correlation coefficient (MCC) was chosen as the final biomarker and to build the SVM classifier. The test set and another independent cohorts were used to assess the predictive power of the classifier based on the receiver operating characteristic (ROC) curves in the R package pROC [64].

Statistical analysis

GraphPad Prism (v 6.0) and the R program (v 3.6.1) were used for statistical analysis. PCoA with Bray–Curtis distance was used to visualize the phylogenetic similarities across samples. Permutational multivariate analysis of variance (PERMANOVA) (“adonis” function, R package vegan [65]) was applied to explore differences in the microbial or functional composition in terms of β-diversity with 999 permutations. The differences in α-diversity (richness, Shannon, and Simpson) indices, within-group Bray–Curtis distance and the relative abundance of taxa were calculated using the Wilcoxon rank-sum test from sow 16S rRNA data. Redundancy analysis (RDA) was performed at the genus level using the R package vegan. Differences in the relative abundance of the taxa and functional features (KO, GO, and CAZy orthologs and KEGG pathways) from metagenomic data of colostrum samples were determined by LEfSe [51] using the online Huttenhower Galaxy server (http://huttenhower.sph.harvard.edu/galaxy/). A replicate (litter) was considered the experimental unit for analysis of differences in weight gain and diarrhea incidence, which were analyzed by two-way ANOVA. During statistical testing of the α-diversity parameters, the Bray–Curtis distances within groups and differences in the microbial features of piglets were examined by the Scheirer-Ray-Hare test (a nonparametric alternative to two-way ANOVA) with the R package rcompanion [66]. Correlations between metabolites or serum metabolite modules and the relative abundance of species from metagenomic data were tested with the Spearman rank. Spearman’s rank correlation coefficients were calculated using the cor.test function and visualized with a heatmap constructed by the R package pheatmap [67]. The differential abundance of modules was tested by the Wilcoxon rank-sum test. Other figures, such as scatter plots, box plots, histograms, and line charts, were generated by the ggplot2 package [68]. All p values of multiple comparisons in the above analysis were adjusted to the false discovery rate (FDR) using the Benjamini-Hochberg (BH) method except where noted. The threshold of significant difference was set at P<0.05 (*P<0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001), and P < 0.1 was considered a significance trend.

Results

Compositional changes in the fecal microbiota of sows

Twenty-six crossbred sows (Landrace and Yorkshire) in late gestation received a diet supplemented with L. reuteri I5007 from late gestation (days 0–28) to lactation (days 28–42). We first investigated the changes in fecal microbiota composition after I5007 treatment. No significant differences in microbial richness and diversity (Shannon and Simpson index) were found in the intestine across different ages between the two groups (Additional file 1: Fig. S1A). PCoA based on Bray–Curtis distance was used to assess the overall structure of the fecal microbiota, and the results showed that the addition of I5007 did not change the composition of the microbiota visibly (Additional file 1: Fig. S1B). Similar results were observed for the interindividual Bray–Curtis metrics (Additional file 1: Fig. S1C). The α- and β-diversity values of the fecal microbiota showed clear age-dependent progression over the entire experimental period.

At the phylum level, Bacteroidetes, Proteobacteria, and Firmicutes were the most abundant taxa in the fecal microbiota of sows over time, and the relative abundance of Proteobacteria tended to increase from gestation to lactation (Additional file 1: Fig. S1D). There were several significantly different genera at different ages between the two groups (Wilcoxon test, P value <0.05). Among these genera, Anaerostipes at day 14 (Additional file 1: Fig. S1E), Lachnospiracea_incertae_sedis and Mogibacterium at day 28, Ruminococcus at day 35, and Acinetobacter at day 42 exhibited significantly higher relative abundances in the I5007 group than in the control group. These results indicated that L. reuteri I5007 may influence only specific bacterial taxa at a specific age but not the overall community structure in the fecal microbiota of sows.

Alterations in the metabolomic profile of the colostrum

In addition to providing nutrition, breast milk contains a diverse microbiota and active components that are thought to be important for the development of the infant immune system and microbiome [69]. Whether the maternal dietary supplementation of L. reuteri affects the microbial communities and functional composition of colostrum remains unknown. To determine these effects, we performed whole-genome shotgun sequencing of colostrum samples. In contrast to the fecal microbiota composition of sows, the taxonomic profile showed that the 3 most abundant phyla in the colostrum were Actinobacteria, Firmicutes, and Proteobacteria, and the 5 most abundant families were Corynebacteriaceae, Lactobacillaceae, Streptomycetaceae, Burkholderiaceae, and Staphylococcaceae (Additional file 1: Fig. S2A and S2B). Maternal dietary L. reuteri intake increased the abundance of Actinobacteria (37.4% → 47.40%) and decreased that of Proteobacteria (28.03% → 19.19%) (Additional file 2: Table S1a). We further examined the influence of a dietary L. reuteri on the overall microbiome composition in colostrum samples by performing PERMANOVA with the Bray–Curtis distance (Fig. 2A). The L. reuteri supplement tended to alter the species composition (P=0.056) and explained 9.5% of the interindividual variation. The within-group Bray–Curtis metric was significantly lower in the I5007 group than in the control group (P=0.0045) (Fig. 2B). The α-diversity analysis of the milk microbiota showed that there was no obvious alteration among these indices between the two groups (Additional file 1: Fig. S2C).

Fig. 2
figure 2

Alterations in microbial and functional compositions in the colostrum. A A principal coordinate analysis (PCoA) with the Bray–Curtis distance was performed to assess the community structure of all the species’ relative abundances from the metagenome. B The microbial structure dissimilarity was dependent on the Bray–Curtis metric between two groups. The Wilcoxon rank-sum test was used to analyze variation between two groups. **P<0.01. C PCoA plots of all GO terms based on the Bray–Curtis distance. D Histograms of significantly enriched KEGG pathways between the I5007 and control groups based on the criteria of an LDA>2 and P<0.05

Full size image

A total of 112 species showed changes in abundance upon the administration of I5007 with the criteria LDA>2.0 and P<0.05 (Additional file 1: Fig. S3; Additional file 2: Table S1b). Fifty-six of the 112 species were enriched in the I5007 group, which were mostly from the phyla Actinobacteria and Firmicutes, whereas the major species enriched in the control group were of the phylum Proteobacteria. Notably, we also observed that dietary L. reuteri supplementation significantly increased the abundance of Bifidobacterium choerinum. PCoA of the relative abundances of differential species based on the Bray–Curtis distances enabled clear separation of the I5007 and control groups and explained 20.2% of the interindividual variation (Additional file 1: Fig. S2D). To describe the interbacterial patterns of interactions within the milk microbiome, we constructed co-occurrence networks of these altered species from each group based on significant correlations (P<0.05, |R|>0.7) (Fig. 3). The results revealed a more complex network of the I5007 microbial features. The I5007 and control groups shared 23 overlapping edges, while 221 and 189 edges were specific to the I5007 and control groups, respectively. Further insight into the feature network suggested that the I5007 microbial feature network had a higher clustering coefficient, average degree, graph density, betweenness centrality, and degree centrality than that of the control group (Additional file 2: Table S1c). The analysis of the difference between the two networks by bootstrapping node attributes (node degree, closeness centrality, betweenness centrality, and transitivity centrality) using the Kolmogorov–Smirnov test also showed that all these features were significantly different between the two groups (P<0.0001). Notably, there were 19 species and 4 species with more than 10 nodes in the networks of the I5007 and control groups, respectively (Additional file 2: Table S1d and S1e).

Fig. 3
figure 3

Co-occurrence network of the significantly different species. Edges representing significant SparCC correlations indicate |r|>0.7 and p<0.05. Light blue lines represent a significant negative correlation, and light red lines represent a significant positive correlation. The size of the points represents the degree of the node. The thickness of the line is proportional to the value of correlation. The node color represents the enrichment of the species in the I5007 (red) and control (blue) groups

Full size image

To characterize the functional changes in the microbial community in milk after I5007 treatment, we annotated the metagenomic gene catalogs against the KEGG, GO, and CAZy databases. The PERMANOVA test based on Bray–Curtis distance revealed that the dietary L. reuteri had a significant effect on the functional structure based on GO terms (Fig. 2C). LEfSe (LDA>2.0, P<0.05) revealed that 70 KOs were significantly changed between the two groups (Additional file 2: Table S1f). Forty-four of the 70 KOs were aligned to KEGG pathways and were mainly involved “metabolism,” “genetic information processing,” and “environmental information processing.” Nineteen of the KOs were aligned to protein families, which were mainly involved in “genetic information processing” and “signaling and cellular processes.” Pathway enrichment analysis revealed that 9 KEGG pathways were significantly different between the two groups (Fig. 2D). The upregulated KEGG pathways in the I5007 group included lysine biosynthesis and glycolysis/gluconeogenesis, whereas the major KEGG pathways enriched in the control group were linked to several bacterial environmental responses (e.g., bacterial invasion of epithelial cells, bacterial chemotaxis, biosynthesis of siderophore group nonribosomal peptides, and flagellar assembly), and these were only positively correlated with the differentially abundant species in the control group (Additional file 1: Fig. S4). PCoA showed that there was no statistically significant difference among CAZyme profiles using the Bray–Curtis distance between the two groups (Fig. S5A). We also measured the concentrations of several metabolites produced by microbial metabolism. The results showed that maternal dietary L. reuteri intake significantly influenced the level of lactate in the colostrum (Additional file 1: Fig. S5B). The concentrations of both lactate and propionate changed depending on age (Additional file 1: Fig. S5B and S5C). There were no differences in other SCFAs (data not shown).

Changes in the metabolite features of umbilical cord blood serum

The metabolic products derived from the microbiota and host could enter the bloodstream and play an important role in host physiology. As we observed that dietary administration of L. reuteri modulated the colostrum microbiome, we wanted to determine whether the metabolite features of umbilical cord blood serum were also affected by L. reuteri. We further explored the untargeted serum metabolome profiles via UPLC-TOF-MS in both the positive ion mode (ES+) and negative ion mode (ES−). We identified a total of 1087 metabolites after eliminating impurity peaks and removing repetitive ions in both modes for further analyses. Based on the OPLS-DA models of all the metabolite profiles, we found that there was a clear separation between the two groups (Fig. 4A). Based on the criteria of a VIP>1 and P<0.05, we identified 19 metabolites that were significantly altered by supplementation with L. reuteri. Fifteen of the 19 metabolites were enriched in the I5007 group, and these metabolites could be grouped into organoheterocyclic compounds, phenylpropanoids and polyketides, lipids and lipid-like molecules, organic acids and derivatives, organic nitrogen compounds, and organic oxygen compounds. The other 4 metabolites were enriched in the control group, and all of these metabolites were grouped into organic acids and derivatives (Fig. 4B). In addition to nontargeted metabolomic profiling, we also examined the concentrations of SCFAs, including formate, acetate, propionate, lactate, butyrate, isobutyrate, and valerate in umbilical cord blood serum, but no difference was found between the I5007 and control groups (data not shown).

Fig. 4
figure 4

Alterations in the serum metabolite features and the relationship with the microbiota of sows. A Scatter plot of orthogonal projection to latent structures discriminant analysis (OPLS-DA) results for the serum metabolome across the two groups. B Heatmap showing the levels of 13 significantly different serum metabolites between the I5007 and control groups. Metabolites meeting the criteria VIP>1 and P<0.05. C Coinertia analysis of the relationship between 13 differential serum metabolites and 112 differentially abundant species in the colostrum. PCs represent the two first principal components from the CIA. The differences were analyzed by the Monte Carlo test

Full size image

In complementary analyses, we classified these 1087 serum metabolites into 25 different coabundance modules (excluding the gray module) of closely associated metabolites based on WGCNA (Additional file 2: Table S1g). By abundance comparison, we found that three modules differed between the I5007 and control groups (Additional file 1: Fig. S6). Several metabolites in the MEblack (2-α-mannobiose), MElightcyan (2,3-dinor-8-iso prostaglandin-Fα, Gly-His-Lys, Arg-Glu), and MEpink (sulfallate, ethylene glycol dodecyl ether sulfate, eplerenone hydroxy acid, 5-heptenoic acid and 1-o-(9z-octadecenyl)-sn-glycero-2,3-cyclic-phosphate) modules also overlapped with those identified as differential metabolites between the two groups above (Fig. 4B).

Next, we investigated whether covariation existed between the serum metabolites and microbiota in sows, and the CIA approach followed by a Monte Carlo test was used to assess the association between two data sets. The differential species in the colostrum were significantly associated with the altered metabolites (Fig. 4C). Moreover, the RV coefficient was lower and the p value was higher when comparing the CIA results of the altered species and all serum metabolites, which further indicated covariation between the markedly different metabolites and the differential microbiota (Additional file 1: Fig. S7A). In addition, no association was observed between the serum metabolites and fecal microbiota (Additional file 1: Fig. S7B and S7C).

Dietary supplementation and oral administration of L. reuteri both modulated the fecal microbiota in piglets

We further examined whether maternal dietary L. reuteri supplementation influenced the fecal microbiota composition of piglets from birth (day 0) to day 28. Analysis of microbiota composition by 16S sequencing indicated that dietary L. reuteri supplementation increased the Shannon (P=0.02) and Simpson (P=0.03) indices in the meconium of newborn piglets, and an increasing trend was observed for richness (P=0.07) (Fig. 5A). A similar result was observed for the PCoA based on the Bray–Curtis distance at the OTU level, and dietary L. reuteri regulated the overall microbial structure (P=0.042) (Fig. 5C). To explore in detail the change in the microbiota, we analyzed the relative abundances of the genera that were different between the two groups. Compared to the control group, dietary L. reuteri supplementation also highly enriched the abundances of 21 bacterial taxa at the genus level at day 0, such as Romboutsia (0.97% → 2.06%), Lactobacillus (1.77% → 4.24%), Blautia (0.12% → 0.50%), Butyricicoccus (0.05% → 0.11%), and Megasphaera (0.02% → 0.36%) (P<0.05, Fig. 5E). Maternal dietary L. reuteri intake did not influence the α-diversity (except for the richness index at day 3) or β-diversity of the fecal microbiota in piglets at later time points (Additional file 1: Fig. S8A-8D; Additional file 2: Table S1h).

Fig. 5
figure 5

Modulatory effect of L. reuteri on the fecal microbiota in piglets. A Boxplots of α-diversity (richness, Shannon, and Simpson index) at day 0. The median of the data is shown. The Wilcoxon rank-sum test was used to analyze the variation between two groups. B Boxplots of α-diversity (richness, Shannon, and Simpson index) at day 28. Differences were analyzed by two-way ANOVA based on the Scheirer-Ray-Hare test. PCoA with Bray–Curtis distance was performed to assess the microbiota structure at C day 0 and D day 28. E Bar graph showing significant differentially abundant genera between the L. reuteri and control groups at day 0. The data are expressed as the average relative abundance of genera in each group. The Wilcoxon rank-sum test was used to analyze the variation between two groups. F Bar graph of significant differentially abundant genera between the Oral and Nonoral groups at day 3. G The effect of maternal dietary supplementation and oral intake of L. reuteri on relative microbiota maturity at different time points. The Wilcoxon rank-sum test or two-way ANOVA was used to analyze the variation. ns, not significant; *P <0.05; **P<0.01; ****P <0.0001. The data are expressed as the mean ± SEM. Diet indicates dietary supplementation with L. reuteri or not; group indicates the oral administration of L. reuteri or not

Full size image

Oral administration of L. reuteri significantly increased the α-diversity of the fecal microbiota in piglets after weaning (Fig. 5B) and at day 3 (Additional file 1: Fig. S8A). For the overall microbiota composition, oral intake explained 4.5% (P=0.016) and 5.3% (P=0.006) of the interindividual variation according to PERMANOVA based on Bray–Curtis metrics at day 28 (Fig. 5D) and day 3 (Additional file 2: Table S1h), respectively. Since maternal dietary L. reuteri intakes only influenced the microbiota composition of newborn piglets, subsequent analyses of the change in taxa at the genus level focused on the oral administration of L. reuteri, and the Wilcoxon rank-sum test was used to analyze the difference. At day 3, oral L. reuteri intake significantly decreased the abundances of Escherichia/Shigella (35.77% → 27.81%) and Enterococcus (16.83% → 10.53%), and increased the abundances of Clostridium_XlVa (2.81% → 4.5%), Clostridium_XlVb (0.54% → 0.75%), Lactobacillus (2.82% → 7.1%), and Ruminococcus (0.002% → 0.01%) (P<0.1, Fig. 5F). At day 28, the abundances of Blautia (3.07% → 1.87%), Succinivibrio (2.90% → 1.10%), Terrisporobacter (0.76% → 0.11%), and Clostridium_XlVb (0.13% → 0.06%) were higher in the Oral group than that in the Nonoral group (Additional file 1: Fig. S8E). OTU-level clustering of the longitudinal samples indicated clear variation in the microbiota profiles between the Oral and Nonoral groups (Additional file 1: Fig. S8F). The clustering of the Oral group included four stages, namely, day 0, day 3–day 7, day 14–day 21, and day 28, while that of the Nonoral groups included five stages.

We also examined the effect of maternal dietary supplementation and oral intake of L. reuteri on fecal microbiota maturation in piglets during early life. To identify the age-dependent development of the fecal microbiota in piglets, the random forest model derived from the relative abundance of all species in the control group (neither dietary supplementation nor oral L. reuteri intake) was regressed against the chronological age of the piglets at different time points. The top 19 age-specific taxa were identified based on tenfold cross-validation with five repeats. Then, these top taxa in the control group were used to build the random forest model (90.86% variation explained) and employed to define the microbiota age across all four groups (Additional file 1: Fig. S8G). The relative microbiota maturity in the I5007_Oral, Control_Oral, and Control_Nonoral groups was further compared to that in the Control_Nonoral group. The development of the natural fecal microbiota followed a smooth line that showed a gradual increase with age (Additional file 1: Fig. S8H). The development of the microbiota in the other three groups exhibited a smooth curve that featured an early-maturation pattern, especially in the I5007_Oral group. Both maternal dietary supplementation and oral intake influenced the relative maturity of the fecal microbiota in piglets, and the maternal effects were stronger than those of oral intake (Fig. 5G). Specifically, the relative microbiota maturity in the I5007 group was higher at day 0 (P<0.01, Wilcoxon rank-sum test) but significantly lower at the later time points (day 14, day 21, and day 28). In addition, compared to the Nonoral group, the Oral group exhibited higher relative microbiota maturity values at day 28 (P<0.05), and these values did not change at the other ages.

To explore the potential relationships between the circulating metabolites in cord blood serum and the microbiota composition in the meconium, a correlation matrix was generated for the 19 significantly altered metabolites and 23 differentially abundant genera using Spearman correlation analysis (Fig. 6A). The heatmap revealed that I5007-enriched oleamide and palmitoleoyl ethanolamide were positively correlated with the abundance of several beneficial bacteria, including Blautia, Butyricicoccus, Clostridium_IV, Lactobacillus, Megasphaera, Ruminococcus, and Ruminococcus2. A similar result observed with RDA also showed that palmitoleoyl ethanolamide and oleamide significantly contributed to the alterations in microbiota composition (P ≤ 0.05) and were positively correlated with the most significant genera (Additional file 1: Fig. S9A). In addition, the levels of 5-heptenoic acid (R=−0.59, P=0.033) and cinchonidine (R=−0.60, P=0.029) were negatively correlated with the abundance of Escherichia/Shigella, which are a potential pathogen in animals with diarrhea (Additional file 1: Fig. S9C). The CIA also showed that the meconium microbiota and metabolites shared similar trends (Fig. 6B and Additional file 1: Fig. S9B). Notably, the differential metabolites were the main contributors to the correlation between the microbiota and metabolites.

Fig. 6
figure 6

The relationship between serum metabolite features and meconium microbiota. A Heatmap of Spearman’s rank correlations between differential metabolites in umbilical cord blood serum and significant genera in the meconium. The correlation coefficients in each square represent positive (red) and negative (blue) correlations. The color intensity is proportional to the absolute value of Spearman’s rank correlation values. Statistically significant correlations are marked with *P <0.05, **P<0.01, or ***P <0.001. The upper panel represents the control-enriched (green) and I5007-enriched (red) general metabolites, and the left panel represents the control-enriched (green) and I5007-enriched (red) metabolites with differential abundance between the two groups. B Coinertia analysis of the relationship among 13 differential serum metabolites and 21 differentially abundant genera in the meconium using the Bray–Curtis metric. Blue and red represent microbiota and metabolites, respectively. PCs represent the first 2 principal components from the coinertia analysis. The differences were analyzed by the Monte Carlo test

Full size image

Maternal dietary supplementation and oral administration of L. reuteri conferred the piglets with growth benefits

To evaluate the performance in growth promotion, we measured the average daily gain, weight change, and diarrhea incidence of piglets. During the whole trial of 28 days, oral administration of I5007 significantly increased the average daily gain of piglets, but maternal dietary intake did not influence this parameter (Fig. 7A). Notably, the I5007_Oral group had the highest average daily gain compared with the other three groups. Similarly, oral administration but not dietary intake of I5007 resulted in a higher average daily gain from day 22 to day 28 (Additional file 1: Fig. S10A). Both maternal dietary intake and oral administration of I5007 increased the weight changes on day 21 and day 28, and these two methods in combination performed the best (Additional file 1: Fig. S10B). Diarrhea is a key negative factor that increases mortality and reduces the growth performance of piglets during early life. We next examined the effect of L. reuteri on diarrhea incidence in piglets. The results showed that oral administration of I5007 promoted diarrhea resistance during the preweaning and postweaning phases (Fig. 7B, C). We also found a significant reduction in the levels of the proinflammatory cytokine IL-6 under oral administration of I5007 in the serum of piglets at day 21 (Fig. 7D). Interestingly, there was no effect of oral administration of I5007 on the activity of SOD and the concentration of MDA, but maternal dietary intake significantly increased the SOD activity and decreased the MDA level in the serum of piglets on day 21 (Fig. 7E, F). We assumed that I5007 treatment also changed the levels of proinflammatory cytokines and MDA, as well as SOD activity, in the cord blood serum of sows. The results showed that dietary I5007 intake only decreased the concentrations of the proinflammatory cytokines TNF-α and IL-6 in the cord blood serum (Additional file 1: Fig. S11A and S11B).

Fig. 7
figure 7

Weight gain, diarrhea incidence, inflammatory cytokines, and antioxidation indices under maternal dietary intake and oral administration of L. reuteri. A Average daily gain of piglets during the whole trial of 28 days. B Diarrhea incidence of piglets during days 1–21 before weaning (B) and days 22–28 after weaning (C). The levels of the proinflammatory cytokine IL-6 (D) and MDA (E) in the serum of piglets at day 21. F The enzyme activity of SOD in the serum of piglets at day 21. U is the international unit of enzyme activity. The data are shown as the mean ± SEM. Differences among treatments were analyzed by two-way ANOVA. ns, not significant; *P <0.05; **P<0.01. Diet indicates dietary supplementation with L. reuteri or not; group indicates the oral administration of L. reuteri or not

Full size image

Dietary supplementation and oral administration of L. reuteri modulated diarrhea-associated bacteria

Since diarrhea alters the fecal microbiota composition (Additional file 1: Fig. S12), we further determined whether the dietary supplementation and oral administration of L. reuteri could influence the structures of key microbes associated with diarrhea in piglets during early life. We first built a machine learning model. Using the mRMR method, the top 19 OTUs had the highest MCC values and were chosen as the final markers to construct the SVM classifier (Additional file 1: Fig. S13A). These OTUs in the model were primarily members of Ruminococcaceae, Lachnospiraceae, and Enterococcaceae (Additional file 2: Table S1i). The predictive power of this model was evaluated by the area under the curve (AUC) of the receiver operating characteristic (ROC). This SVM classifier showed a high AUC of 97% and a 95% confidence interval of 93.4 to 100% for the independent test data set (Additional file 1: Fig. S13B). To further evaluate whether the classifier could be generalized for prediction in other samples, we used an independent validation cohort and found a moderately good performance (AUC = 73.4%), although not as good as that in the original test cohort (Additional file 1: Fig. S13B). Next, we examined the effects of maternal dietary intake and oral administration of L. reuteri on the alteration in α-diversity and β-diversity within these 19 OTUs (Additional file 1: Fig. S14). The PCoA showed that dietary intake of L. reuteri regulated the overall microbial structure based on the Bray–Curtis distance and explained 4.4% of the interindividual variation at day 3. Moreover, the richness, Shannon and Simpson indices revealed a change in the richness and diversity of these OTUs after 28 days of oral administration of L. reuteri.

Discussion

In the present study, we used a combination of taxonomic, metagenomic, and metabolomic approaches, and the results revealed that L. reuteri, administered either directly or indirectly through vertical transfer, improved the development and maturation of fecal microbiota and subsequently promoted the early growth of piglets.

These results are consistent with a previous report showing that L. reuteri had little effect on the fecal microbiota composition in healthy adults [70]. The administration of L. reuteri to sows in the diet for 4 weeks did not change their fecal microbiota composition, which may be explained by the fact that the microbiomes of adult individuals are very mature and stable, making it difficult for exogenous probiotics to colonize the intestine in large numbers and affect the community. Although whether the microbial colonization of newborns begins prior to birth remains controversial, it is clear that diverse microbes from the maternal gut bacteria can be vertically transmitted to the infant gut and might serve as seeding bacteria to prime the development of the infant gut microbiome at subsequent time points [19, 71]. Remarkably, the taxonomic composition and functional profiles of the colostrum were influenced by maternal dietary supplementation with L. reuteri, as the biodiversity and microbial interactions in these colostrum samples were significantly different from those of normal colostrum microbiota. The bacteria belonging to the genera Brachybacterium, which was identified as the commensal microorganism in the milk microbiome, were significantly enriched in the colostrum of L. reuteri treated group. Brachybacterium has the ability to rapidly convert lactose to lactate [72], which is consistent with our result that the concentration of lactate was higher in the colostrum of L. reuteri treated groups. Species network analysis of colostrum of L. reuteri treated group and normal colostrum showed that the former had a more complex microbial community. Generally, microbiota with enhanced biodiversity are more resilient and adaptable to stress and less susceptible to pathogen infection than those with less diversity [73]. The “core” species with more than 10 nodes in the L. reuteri treated group network were positively associated with enriched pathways, including glycolysis/gluconeogenesis and lysine biosynthesis. Moreover, a functional KEGG pathway, bacterial invasion of epithelial cells, was enriched and significantly associated with the enriched species in the normal colostrum. Taken together, our results indicated that maternal dietary supplementation with L. reuteri could markedly modulate the microbiota structure and functional composition in the colostrum.

Notably, maternal diet supplementation with L. reuteri had a strong overall impact on the fecal microbiota composition in newborn piglets. Relative to those in the control group, most of the bacteria that differentially colonized the intestines of newborn piglets have been reported to have particularly important effects on improving host health during neonatal life (e.g., Lactobacillus, Blautia, Ruminococcus, and Clostridium_IV ) [74]. Moreover, the oral administration of L. reuteri also increased the abundances of Lactobacillus, Eubacterium, and Ruminococcus and greatly decreased the abundance of the Escherichia/Shigella. Escherichia coli is a keystone diarrhea-causing enteropathogen during the suckling period and has a severe impact on animal health [75]. This result indicated that L. reuteri could inhibit the colonization of the pathogen in the piglet intestine indirectly or directly and thus decrease the incidence of diarrhea before weaning. Interestingly, neither maternal dietary supplementation nor oral administration affected the fecal microbiota composition during the middle (days 7 and 14) and late (day 21) stages of nursing. This result may be explained by the fact that the development and maturation of the gut microbiota during early life is a dynamic and nonrandom process that is influenced by various factors, such as the mode of delivery [13], host genetics [76], feeding mode [77], and antibiotic usage [78]. The “natural” developmental characteristics of the infant microbiome may overshadow the effect of L. reuteri supplementation. Our findings confirmed that the oral administration of L. reuteri reproduced the modulation of the fecal microbiota composition and reduced diarrhea after weaning (day 28) despite the cessation of maternal L. reuteri administration. The relative abundances of Blautia and Butyricicoccus were higher in the probiotic group at birth and after weaning than those in the control group. Blautia and Butyricicoccus are common butyrate-producing bacteria in the intestine [74, 79]. The regulatory effect of butyrate on fecal immunity and gut health has been extensively studied and recognized [80,81,82]. These findings were consistent with previous studies showing that dietary supplementation with L. reuteri increased the concentration of SCFAs in piglet feces [83, 84], suggesting L. reuteri drives the enrichment of several functional microbes to modulate the development and maturation of the fecal microbiota in piglets.

Metabolic profiling revealed significant pattern differences induced by the maternal dietary supplementation with L. reuteri. Among the significantly changed metabolites, oleamide and palmitoleoyl ethanolamide were positively correlated with the most enriched genus in the L. reuteri group. This result suggested that these two metabolites may drive the alteration of fecal microbiota between the two groups in newborn piglets. Previous reports have shown that oleamide and palmitoleoyl ethanolamide have anti-inflammatory effects in vitro [85] and in animal models [86]. We also observed that the serum concentrations of the proinflammatory factors TNF-α and IL6 were decreased after the consumption of L. reuteri. Consistent with our study, supplementation with other probiotics, namely, Pediococcus pentosaceus KID7 and Lactobacillus rhamnosus LRa05, increased the levels of oleamide [87] and palmitoleoyl ethanolamide [88], respectively. One study reported that oleamide was found in the supernatant of another Lactobacillus species, Lactobacillus sakei probio65 [89]. In addition, we observed that the differential metabolites cinchonidine and 5-heptenoic acid were negatively correlated with the abundance of Escherichia/Shigella. The former was reported to have antibacterial activity [90], and the latter was shown to attenuate bacterial LPS-induced inflammation [91]. However, whether L. reuteri modulate these key metabolites directly or indirectly via the metabolism of the host remains unclear, and the mechanism requires further investigation. In addition, coinertia analysis showed marked covariation between serum metabolites and the fecal microbiota in newborn piglets. This strongly suggested that the microbiota of newborn piglets was modulated by metabolites during mother-fetal nutrition transfer via the umbilical cord blood. In summary, our data suggest that the structural characteristics of the fecal microbiota in newborn piglets were associated with the alteration of metabolite profiles in umbilical cord blood serum caused by supplementation with L. reuteri in the maternal diet.

The development and maturation of microbiota in early life was shown to affected immune response, to promote growth and to potentially decrease disease susceptibility [2]. Diarrhea is a key negative factor that increases mortality and reduces the growth performances of piglets during early life. Our results suggested that the oral administration of I5007 promoted diarrhea resistance and decreased inflammation. Consistent with previous studies, the addition of Lactobacillus strains promoted growth and immunological parameters in broilers [78] and piglets [83, 92]. Maternal supplementation of L. reuteri enhanced the antioxidant ability of offspring. This result may be explained by the fact that L. reuteri modulated several key microbes in the piglets. The maternal supplementation of L. reuteri was confirmed to affect the fecal microbiota richness of piglets on day 3, which was potentially due to the regulation of L. reuteri on colostrum. Notably, both the maternal dietary intake and oral administration of I5007 increased the weight changes in piglets, and these two methods exhibited the best weight changes.

Consistent with a previous study, diarrhea disrupted the intestinal microbiota, characterized by the presence of distinctive microbial markers belonging to Enterococcus spp. and Prevotella spp. [93]. Among the 19 optimal OTU-based microbial markers, several species have been reported to impact the host functionally or pathogenically. Clostridium species belonging to Clostridium cluster IV promote the development of the intestinal immune system [94]. The genus Facklamia was reported to be enriched upon the administration of L. rhamnosus GG to pigs challenged with Salmonella enterica [95]. Moreover, we observed that the maternal dietary supplementation and oral administration of L. reuteri regulated the changes in the diversity of these microbial biomarkers associated with diarrhea. However, we observed that the predictive accuracy was decreased in the independent validation cohort, which may have been due to the high intercohort variability. Thus, these results revealed that L. reuteri intake by both sows and piglets promoted growth and diarrhea resistance, possibly by driving the dynamics of key fecal microorganisms in piglets during early life.

Indeed, a small number of studies have provided preliminary evidence that the maternal dietary supplementation or oral administration of L. reuteri modulates the infant microbiota [13, 27, 29, 96]. These studies focused mainly on alterations in the gut microbiome and did not examine maternal changes other than those in the intestinal microbiota. Our study furthers our global understanding of the functional variations in the metabolite features of umbilical cord blood serum and in the metabolome profiles in colostrum, as well as in infant intestinal microbiota, as determined by multiomics analysis. In addition, the modulation of diarrhea-associated microbial markers by L. reuteri further illustrates that probiotics are an effective method for preventing diarrhea in piglets during early life, especially given that the use of antibiotics is gradually being prohibited. However, future studies are needed to (1) investigate the mechanism by which key metabolites modulate the microbiota composition in the intestines of infants as well as how they impact the intestinal immune system during the neonatal period and (2) examine the potential interactions among the metabolites, key microbes, and L. reuteri during mother-infant transmission.

Conclusions

In conclusion, both maternal dietary supplementation and oral administration of L. reuteri modulate and accelerate the maturation of the fecal microbiota composition in piglets during early life. The beneficial effects of L. reuteri may improve through the regulation of metabolite profiles in the blood of sow during pregnancy and microbes in the colostrum of sows, leading to manipulation of the infant fecal microbiota and immune function. Thus, our findings support the utility of probiotics as an effective means to improve the dysfunctional microbiota and potentially promote the development of the infant fecal microbiome and gut health during the early postnatal period of life.

Availability of data and materials

The raw Illumina sequence data of sows and piglets and the independent validation cohort generated in the present study are available in the sequence read archive (SRA) at NCBI under Bioproject accessions # PRJNA701781 and # PRJNA730972, respectively. The metagenome sequence data of the colostrum are available in NCBI SRA under Bioproject accession #PRJNA701802. All of these data sets will be released on 31 December 2023.

Abbreviations

CFU:

Colony-forming unit

PCoA:

Principal coordinate analysis

KEGG:

Kyoto Encyclopedia of Genes and Genome

OPLS-DA:

Orthogonal projection to latent structures discriminant analysis

CIA:

Coinertia analysis

WGCNA:

Weighted correlation network analysis

SCFAs:

Short-chain fatty acids

LDA:

Linear discriminant analysis

LEfSe:

Linear discriminant analysis effect size

RV:

Regression vector

ADG:

Average daily gain

TNF-α:

Tumor necrosis factor

IL-6:

Interleukin 6

MDA:

Malondialdehyde

SOD:

Superoxide dismutase

mRMR:

Minimal redundancy maximal relevance

LOOCV:

Leave-one-out cross-validation

MCC:

Matthews correlation coefficient

ROC:

Receiver operating characteristic

PERMANOVA:

Permutational multivariate analysis of variance

RDA:

Redundancy analysis

FDR:

False discovery rate

BH:

Benjamini-Hochberg

SEM:

Standard error of the mean

References

  1. Suganya K, Koo B-S. Gut–brain axis: role of gut microbiota on neurological disorders and how probiotics/prebiotics beneficially modulate microbial and immune pathways to improve brain functions. Int J Mol Sci. 2020;21:7551.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tamburini S. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22:10.

    Article  Google Scholar 

  4. Saavedra JM, Dattilo AM. Early development of intestinal microbiota: implications for future health. Gastroenterol Clin N Am. 2012;41:717–31.

    Article  Google Scholar 

  5. Rautava S, Luoto R, Salminen S, Isolauri E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat Rev Gastroenterol Hepatol. 2012;9:565–76.

    Article  CAS  PubMed  Google Scholar 

  6. Stinson LF. Establishment of the early-life microbiome: a DOHaD perspective. J Dev Orig Health Dis. 2020;11:201–10.

    Article  PubMed  Google Scholar 

  7. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107:11971–5.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Korpela K, Salonen A, Virta LJ, Kekkonen RA, de Vos WM. Association of early-life antibiotic use and protective effects of breastfeeding: role of the intestinal microbiota. JAMA Pediatr. 2016;170:750–7.

    Article  PubMed  Google Scholar 

  10. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1:6.

    Article  Google Scholar 

  11. Korpela K, Salonen A, Virta LJ, Kumpu M, Kekkonen RA, de Vos WM. Lactobacillus rhamnosus GG Intake Modifies Preschool Children’s Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use. PLoS One. 2016;11:e0154012.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Yang Y, Zhong Z, Wang B, Xia X, Yao W, Huang L, et al. Early-life high-fat diet-induced obesity programs hippocampal development and cognitive functions via regulation of gut commensal Akkermansia muciniphila. Neuropsychopharmacology. 2019;44:2054–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Korpela K, Salonen A, Vepsäläinen O, Suomalainen M, Kolmeder C, Varjosalo M, et al. Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants. Microbiome. 2018;6:182.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335–41.

    Article  PubMed  Google Scholar 

  15. Hagihara M, Kuroki Y, Ariyoshi T, Higashi S, Fukuda K, Yamashita R, et al. Clostridium butyricum modulates the microbiome to protect intestinal barrier function in mice with antibiotic-induced dysbiosis. iScience. 2020;23:100772.

    Article  CAS  PubMed  Google Scholar 

  16. Wang G, Huang S, Cai S, Yu H, Wang Y, Zeng X, et al. Lactobacillus reuteri ameliorates intestinal inflammation and modulates gut microbiota and metabolic disorders in dextran sulfate sodium-induced colitis in mice. Nutrients. 2020;12:2298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell. 2012;149:1578–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Tsai C-C, Hsih H-Y, Chiu H-H, Lai Y-Y, Liu J-H, Yu B, et al. Antagonistic activity against Salmonella infection in vitro and in vivo for two Lactobacillus strains from swine and poultry. Int J Food Microbiol. 2005;102:185–94.

    Article  PubMed  Google Scholar 

  19. Perez-Muñoz ME, Arrieta M-C, Ramer-Tait AE, Walter J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome. 2017;5:48.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Walker RW, Clemente JC, Peter I, Loos RJF. The prenatal gut microbiome: are we colonized with bacteria in utero? Pediatr Obes. 2017;12(Suppl 1):3–17.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ferretti P. Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome. 2018;24:133–45.

  22. Liu H, Zeng X, Zhang G, Hou C, Li N, Yu H, et al. Maternal milk and fecal microbes guide the spatiotemporal development of mucosa-associated microbiota and barrier function in the porcine neonatal gut. BMC Biol. 2019;17:106.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Liu X, Li X, Xia B, Jin X, Zou Q, Zeng Z, et al. High-fiber diet mitigates maternal obesity-induced cognitive and social dysfunction in the offspring via gut-brain axis. Cell Metab. 2021;4(33):923–38.

    Article  Google Scholar 

  24. Kim S, Kim H, Yim YS, Ha S, Atarashi K, Tan TG, et al. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature. 2017;549:528–32.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Geddes DT, Prescott SL. Developmental origins of health and disease: the role of human milk in preventing disease in the 21(st) century. J Hum Lact. 2013;29:123–7.

    Article  PubMed  Google Scholar 

  26. Martí M. Effects of Lactobacillus reuteri supplementation on the gut microbiota in extremely preterm infants in a randomized placebo-controlled trial. Cell Rep Med. 2021;2:100206.

  27. Alcon-Giner C. Microbiota supplementation with Bifidobacterium and Lactobacillus modifies the preterm infant gut microbiota and metabolome: an observational study. Cell Rep Med. 2020;1:100077.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. O’Brien CE, Meier AK, Cernioglo K, Mitchell RD, Casaburi G, Frese SA, et al. Early probiotic supplementation with B. infantis in breastfed infants leads to persistent colonization at 1 year. Pediatr Res. 2022;91:627–36.

  29. Dotterud CK, Avershina E, Sekelja M, Simpson MR, Rudi K, Storrø O, et al. Does maternal perinatal probiotic supplementation alter the intestinal microbiota of mother and child? J Pediatr Gastroenterol Nutr. 2015;61:200–7.

    Article  CAS  PubMed  Google Scholar 

  30. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol. 2004;70:1176–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Wang M, Wu H, Lu L, Jiang L, Yu Q. Lactobacillus reuteri promotes intestinal development and regulates mucosal immune function in newborn piglets. Front Vet Sci. 2020;7:42.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hou C. Complete genome sequence of Lactobacillus reuteri I5007, a probiotic strain isolated from healthy piglet. J Biotechnol. 2014;179:63–4.

    Article  CAS  PubMed  Google Scholar 

  33. Wang X, Yang F, Liu C, Zhou H, Wu G, Qiao S, et al. Dietary supplementation with the probiotic Lactobacillus fermentum I5007 and the antibiotic aureomycin differentially affects the small intestinal proteomes of weanling piglets. J Nutr. 2012;142:7–13.

    Article  CAS  PubMed  Google Scholar 

  34. Hou C, Liu H, Zhang J, Zhang S, Yang F, Zeng X, et al. Intestinal microbiota succession and immunomodulatory consequences after introduction of Lactobacillus reuteri I5007 in neonatal piglets. PLoS One. 2015;10:e0119505.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. The pig: a model for human infectious diseases. Trends Microbiol. 2012;20:50–7.

    Article  CAS  PubMed  Google Scholar 

  36. Guilloteau P, Zabielski R, Hammon HM, Metges CC. Nutritional programming of gastrointestinal tract development. Is the pig a good model for man? Nutr Res Rev. 2010;23:4–22.

    Article  PubMed  Google Scholar 

  37. Heinritz SN, Mosenthin R, Weiss E. Use of pigs as a potential model for research into dietary modulation of the human gut microbiota. Nutr Res Rev. 2013;26:191–209.

    Article  PubMed  Google Scholar 

  38. Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick J-S, Frokiaer H, et al. Early nutrition and immunity - progress and perspectives. Br J Nutr. 2006;96:774–90.

    CAS  PubMed  Google Scholar 

  39. Vo A-TE, Jedlicka JA. Protocols for metagenomic DNA extraction and Illumina amplicon library preparation for faecal and swab samples. Mol Ecol Resour. 2014;14:1183–97.

    Article  CAS  PubMed  Google Scholar 

  40. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–1.

    Article  CAS  PubMed  Google Scholar 

  41. Rognes T, Flouri T, Nichols B, Quince C, Mahé F. VSEARCH: a versatile open source tool for metagenomics. PeerJ PeerJ Inc. 2016;4:e2584.

    Article  Google Scholar 

  42. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42:D633–42.

    Article  CAS  PubMed  Google Scholar 

  43. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014;15:R46.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Li D, Liu C-M, Luo R, Sadakane K, Lam T-W. MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics. 2015;31:1674–6.

    Article  CAS  PubMed  Google Scholar 

  47. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30:2068–9.

    Article  CAS  PubMed  Google Scholar 

  48. Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 2006;22:1658–9.

    Article  CAS  PubMed  Google Scholar 

  49. Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2015;12:59–60.

    Article  CAS  PubMed  Google Scholar 

  51. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem. 2009;81:10038–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 2008;24:719–20.

    Article  CAS  PubMed  Google Scholar 

  54. Jain A, Li XH, Chen WN. An untargeted fecal and urine metabolomics analysis of the interplay between the gut microbiome, diet and human metabolism in Indian and Chinese adults. Sci Rep. 2019;9:9191.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLOS Computational Biology. Public Library of. Science. 2012;8:e1002687.

    CAS  Google Scholar 

  56. Mora A, Donaldson IM. iRefR: an R package to manipulate the iRefIndex consolidated protein interaction database. BMC Bioinformatics. 2011;12:455.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Newman MEJ. The structure and function of complex networks. SIAM Rev. 2003;45:167–256.

    Article  Google Scholar 

  58. Banerjee S, Walder F, Büchi L, Meyer M, Held AY, Gattinger A, et al. Agricultural intensification reduces microbial network complexity and the abundance of keystone taxa in roots. ISME J. 2019;13:1722–36.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Breiman L. Random Forests. Mach Learn. 2001;45:5–32.

    Article  Google Scholar 

  60. Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature. 2014;510:417–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Dray S, Chessel D, Thioulouse J. Co-inertia analysis and the linking of ecological data tables. Ecology. 2003;84:3078–89.

    Article  Google Scholar 

  62. Hart GK, Dobb GJ. Effect of a fecal bulking agent on diarrhea during enteral feeding in the critically ill. J Parenter Enter Nutr. 1988;12:465–8.

    Article  CAS  Google Scholar 

  63. Cheng Q, Li J, Fan F, Cao H, Dai Z-Y, Wang Z-Y, et al. Identification and analysis of glioblastoma biomarkers based on single cell sequencing. Front Bioeng Biotechnol. 2020;8:167.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, McGlinn D, et al. vegan: Community Ecology Package. 2020. https://CRAN.R-project.org/package=vegan.

    Google Scholar 

  66. Mangiafico S. rcompanion: functions to support extension education program evaluation. 2021. https://CRAN.R-project.org/package=rcompanion.

    Google Scholar 

  67. Kolde R. pheatmap: Pretty Heatmaps. 2019. https://CRAN.R-project.org/package=pheatmap.

    Google Scholar 

  68. Wickham H, Chang W, Henry L, Pedersen TL, Takahashi K, Wilke C, et al. ggplot2: create elegant data visualisations using the grammar of graphics. 2020. https://CRAN.R-project.org/package=ggplot2.

    Google Scholar 

  69. Sánchez C, Franco L, Regal P, Lamas A, Cepeda A, Fente C. Breast milk: a source of functional compounds with potential application in nutrition and therapy. Nutrients. 2021;13:1026.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016;8:52.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Sindi AS, Geddes DT, Wlodek ME, Muhlhausler BS, Payne MS, Stinson LF. Can we modulate the breastfed infant gut microbiota through maternal diet? FEMS Microbiol Rev. 2021;45:fuab011.

  72. Quigley L, O’Sullivan O, Stanton C, Beresford TP, Ross RP, Fitzgerald GF, et al. The complex microbiota of raw milk. FEMS Microbiol Rev. 2013;37:664–98.

    Article  CAS  PubMed  Google Scholar 

  73. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, et al. Blautia—a new functional genus with potential probiotic properties? Gut Microbes. 2021;13:1–21.

    Article  PubMed  Google Scholar 

  75. Sun J, Du L, Li X, Zhong H, Ding Y, Liu Z, et al. Identification of the core bacteria in rectums of diarrheic and non-diarrheic piglets. Sci Rep. 2019;9:18675.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Turpin W, Espin-Garcia O, Xu W, Silverberg MS, Kevans D, Smith MI, et al. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat Genet. 2016;48:1413–7.

    Article  CAS  PubMed  Google Scholar 

  77. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Gao P, Ma C, Sun Z, Wang L, Huang S, Su X, et al. Feed-additive probiotics accelerate yet antibiotics delay intestinal microbiota maturation in broiler chicken. Microbiome. 2017;5:91.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Boesmans L, Valles-Colomer M, Wang J, Eeckhaut V, Falony G, Ducatelle R, et al. Butyrate producers as potential next-generation probiotics: safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers. mSystems. 2018;3:e00094–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Donohoe DR, Garge N, Zhang X, Sun W, O’Connell TM, Bunger MK, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13:517–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Ghorbani P, Santhakumar P, Hu Q, Djiadeu P, Wolever TMS, Palaniyar N, et al. Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth. Eur Respir J. 2015;46:1033–45.

    Article  CAS  PubMed  Google Scholar 

  82. Levy M, Thaiss CA, Zeevi D, Dohnalová L, Zilberman-Schapira G, Mahdi JA, et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell. 2015;163:1428–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Liu H, Hou C, Wang G, Jia H, Yu H, Zeng X, et al. Lactobacillus reuteri I5007 modulates intestinal host defense peptide expression in the model of IPEC-J2 cells and neonatal piglets. Nutrients. 2017;9:559.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Zhang D, Liu H, Wang S, Zhang W, Wang J, Tian H, et al. Fecal microbiota and its correlation with fatty acids and free amino acids metabolism in piglets after a Lactobacillus strain oral administration. Front Microbiol. 2019;10:785.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Moon S-M, Lee SA, Hong JH, Kim J-S, Kim DK, Kim CS. Oleamide suppresses inflammatory responses in LPS-induced RAW264.7 murine macrophages and alleviates paw edema in a carrageenan-induced inflammatory rat model. Int Immunopharmacol. 2018;56:179–85.

    Article  CAS  PubMed  Google Scholar 

  86. Borrelli F, Romano B, Petrosino S, Pagano E, Capasso R, Coppola D, et al. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol. 2015;172:142–58.

    Article  CAS  PubMed  Google Scholar 

  87. Lee NY, Yoon SJ, Han DH, Gupta H, Youn GS, Shin MJ, et al. Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes. 2020;11:882–99.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Sun M, Wu T, Zhang G, Liu R, Sui W, Zhang M, et al. Lactobacillus rhamnosus LRa05 improves lipid accumulation in mice fed with a high fat diet via regulating the intestinal microbiota, reducing glucose content and promoting liver carbohydrate metabolism. Food Funct. 2020;11:9514–25.

    Article  CAS  PubMed  Google Scholar 

  89. Rather IA, Bajpai VK, Ching LL, Majumder R, Nam G-J, Indugu N, et al. Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model. Saudi J Biol Sci. 2020;27:261–70.

    Article  CAS  PubMed  Google Scholar 

  90. Skogman ME, Kujala J, Busygin I, Leino R, Vuorela PM, Fallarero A. Evaluation of antibacterial and anti-biofilm activities of Cinchona alkaloid derivatives against Staphylococcus aureus. Nat Prod Commun. 2012;7:1173–6.

    CAS  PubMed  Google Scholar 

  91. Maehara T, Higashitarumi F, Kondo R, Fujimori K. Prostaglandin F2α receptor antagonist attenuates LPS-induced systemic inflammatory response in mice. FASEB J. 2020;34:15197–207.

    Article  CAS  PubMed  Google Scholar 

  92. Hu J, Ma L, Nie Y, Chen J, Zheng W, Wang X, et al. A microbiota-derived Bacteriocin targets the host to confer diarrhea resistance in early-weaned piglets. Cell Host Microbe. 2018;24:817–832.e8.

    Article  CAS  PubMed  Google Scholar 

  93. Berkell M, Mysara M, Xavier BB, van Werkhoven CH, Monsieurs P, Lammens C, et al. Microbiota-based markers predictive of development of Clostridioides difficile infection. Nat Commun. 2021;12:2241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337–41.

    Article  CAS  PubMed  Google Scholar 

  95. Zhang W, Wu Q, Zhu Y, Yang G, Yu J, Wang J, et al. Probiotic Lactobacillus rhamnosus GG induces alterations in ileal microbiota with associated CD3-CD19-T-bet+IFNγ+/- cell subset homeostasis in pigs challenged with Salmonella enterica Serovar. Front Microbiol. 2019;10:977.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Martí M, Spreckels JE, Ranasinghe PD, Wejryd E, Marchini G, Sverremark-Ekström E, et al. Effects of Lactobacillus reuteri supplementation on the gut microbiota in extremely preterm infants in a randomized placebo-controlled trial. Cell Rep Med. 2021;2:100206.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

This work was supported by National Natural Science Foundation of China (no. U180220167) and National Key R&D Program of China (no. 2017YFD0500506).

Author information

Author notes

  1. Xiangfang Zeng

    Present address: State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, 100193, China

  2. Shiyan Qiao

    Present address: Beijing Key Laboratory of Biological Feed Additive, China Agricultural University, Beijing, 100193, China

Authors and Affiliations

  1. State Key Laboratory of Animal Nutrition, College of Animal Science and Technology, China Agricultural University, Beijing, 100193, China

    Gang Wang, Xinyu Wang, Yonghang Ma, Shuang Cai, Lijie Yang, Yuxin Fan & Shiyan Qiao

  2. Beijing Key Laboratory of Biological Feed Additive, China Agricultural University, Beijing, 100193, China

    Gang Wang, Xinyu Wang, Yonghang Ma, Shuang Cai, Lijie Yang, Yuxin Fan & Xiangfang Zeng

Authors
  1. Gang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xinyu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yonghang Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shuang Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lijie Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuxin Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiangfang Zeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shiyan Qiao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SYQ and XFZ conceived and designed the study. XYW and YHM conducted the experiments. XYW and YHM collected the samples. LJY and SC performed the analysis of the samples. GW and XYF analyzed the data. GW wrote the manuscript. XFZ and GW revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xiangfang Zeng.

Ethics declarations

Ethics approval and consent to participate

The experiment was approved by the Institutional Animal Care and Use Committee of China Agricultural University (ID: 201605510410554), and all handling procedures were performed according to the guidelines for animal research.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1

. The effects of L. reuteri supplementation on the microbiota composition in the intestine of sows. (A) Dynamic changes in α-diversity (richness, Shannon and Simpson index) between two groups across different ages. The data are expressed as the mean ±SEM. Differences were analyzed by two-way ANOVA based on the Scheirer-Ray-Hare test. (B) PCoA plot based on the Bray–Curtis distance of microbiota composition. Significance was calculated using PERMANOVA. (C) Bray–Curtis dissimilarity between the L. reuteri I5007 and control groups across different ages. The median of the data is shown. Differences were analyzed by two-way ANOVA based on the Scheirer-Ray-Hare test. (D) Histogram showing the relative abundances of the five most abundant phyla in the intestine of sows over time. (E) Heatmap showing the genera that were significantly affected by supplementation with L. reuteri I5007 on a certain day. The data are expressed as the mean relative abundance (%) in each group. The Wilcoxon rank-sum test was used to analyze variation between two groups at the same time point. Diet indicates dietary supplementation with L. reuteri or not; group indicates the oral administration of L. reuteri or not. Figure S2. Alterations in the colostrum microbial composition. Histogram of the structural composition of the microbiota at the phylum level (top 6) (A) and the family level (top 10) (B) in the colostrum samples. Significance was measured using the Wilcoxon rank-sum test. The horizontal bars within the box represent the median. (C) The α-diversity of bacteria was measured using the richness, Shannon and Simpson indices. (D) PCoA plots of significantly different species based on Bray–Curtis distance. Figure S3. Significantly different species between the I5007 and control groups. Histograms of significantly altered species with the criteria LDA>2 and P<0.05 from metagenome data between the two groups. The color of the bar indicates enrichment of the species in the I5007 (green) and control (red) groups. Figure S4. Correlation analysis of KEGG pathways and species in the colostrum. Heatmap of Spearman’s rank correlations between differential KEGG pathways and species from the colostrum metagenome data. Correlation coefficients in each square represent positive (red) and negative (blue) correlations. The color intensity is proportional to the absolute values of Spearman’s rank correlation. Statistically significant correlations are marked with *P <0.05, **P<0.01, and ***P <0.001. The left panel represents the control-enriched (green) and I5007-enriched (red) metabolites or KEGG pathways between the two groups. Figure S5. The microbial gene functions annotated in CAZy, the concentration of acids and the relationship between the serum metabolites and species in colostrum. (A) PCoA based on the Bray–Curtis distances of CAZy orthologs between the I5007 and control groups. Boxplots showing the concentrations of lactate (B) and propionate (C) between the I5007 and control groups at different time points. Diet means dietary supplementation of L. reuteri or not; Group means oral administration of L. reuteri or not. Figure S6. WGCNA analysis of the metabolites features in the umbilical cord blood serum. Box plots of eigenmetabolite levels of the MEdarkgray, MEpink, MElightcyan and MEblack modules between the I5007 and control groups. The Wilcoxon rank-sum test was used to analyze the variation between two groups. Figure S7. Multiomic association studies on the microbiota of sows and the serum metabolome. (A) Coinertia analysis of the relationships between all serum metabolites and 112 differential species in colostrum. Coinertia analysis of the fecal microbiota in sows and the significantly different (B) and all (C) serum metabolites. PCs represent the two first principal components from the CIA. Figure S8. Effect of L. reuteri on the fecal microbiota in piglets of different ages. Boxplots of α-diversity (richness, Shannon and Simpson index) on (A) day 3, (B) day 7, (C) day 14, and (D) day 21. The median of the data is shown. Differences were analyzed by two-way ANOVA based on the Scheirer-Ray-Hare test at the same time point. (E) Bar graph showing significant differentially abundant genera between the Oral and Nonoral groups at day 28. The data are expressed as the average relative abundance of genera in each group. The Wilcoxon rank-sum test was used to analyze variation between two groups. (F) Heatmap showing the clustering of the fecal microbiota at the OTU level in the Oral and Nonoral groups. (G) The top 19 age-specific taxa identified by applying random forest regression of their relative abundances. These biomarker taxa are ranked in descending order of importance to the accuracy of the model. The inset of (G) shows the tenfold cross-validation error as a function of the number of input taxa used to regress against the age of piglets and in the order of variable importance. (H) Microbiota age in different groups predicted by the random forest regression model. The curve is a smoothed spline fit between microbiota age and chronological age, and each circle represents an individual sample. Diet indicates dietary supplementation with L. reuteri or not; group indicates the oral administration of L. reuteri or not. Figure S9. Alterations in serum metabolite features and the relationship with the meconium fecal microbiota. (A) Redundancy analysis (RDA) plot was generated with differential metabolites significantly correlated with at least one differentially abundant genus. Each black circle indicates all the serum samples. Blue arrows indicate the differential serum metabolites (dependent variables). Red arrows indicate the differentially abundant genera (independent variable). The relationship of each independent variable with another variable is equal to the cosine of the angle between the arrows; a small angle indicates a high positive correlation, and opposite directions indicate a negative correlation. (B) Coinertia analysis of the relationship between all serum metabolites and 23 differentially abundant genera in the meconium using the Bray–Curtis metric. Blue and red represent the microbiota and metabolites, respectively. (C) The scatter plots show the correlation of the level of 5-heptenoic acid and cinchonidine (log10 conversion) with the relative abundance of Escherichia/Shigella. Figure S10. Effects of maternal dietary intake and oral administration of L. reuteri on the growth performance of piglets. (A) Average daily weight gain of piglets from day 22 to day 28; (B) Weight change of piglets during day 1-day 28 under maternal dietary intake and oral administration of L. reuteri. The data are expressed as the mean ± SEM. The data are shown as the mean ± SEM. Differences among groups were analyzed by two-way ANOVA. ns, not significant; *P <0.05; **P<0.01. Diet means dietary supplementation of L. reuteri or not; group means oral administration of L. reuteri or not. Figure S11. Concentration of proinflammatory cytokines in the cord blood of sows. The bars show the levels of TNF-α (A) and IL-6 (B) between the I5007 and control groups. The data are shown as the mean ± SEM. Differences between the control and I5007 groups were analyzed by unpaired t-tests (two-tailed). *P <0.05. IL-6, interleukin 6; TNF-α, tumor necrosis factor-α. Figure S12. The overall microbiota composition between diarrheic and healthy individuals. Principal coordinates analysis (PCoA) plots of all OTUs based on Bray–Curtis distance from day 3 to day 28. Red points represent the samples of individuals with diarrhea, and green points represent the samples of healthy individuals. Figure S13. OTU-based classifier used to distinguish diarrheic and healthy individuals. (A) The mRMR method was used to identify diarrhea-associated biomarkers. The IFS curve of the top 100 mRMR OTUs. The x-axis shows the number of OTUs, and the y-axis shows the prediction performance. The peak MCC value was 0.832 when 19 OTUs were chosen. (B) Receiver operating characteristic (ROC) curves for the diarrheic and healthy individuals; 95% confidence intervals (CIs) are indicated by error bars. The blue line represents the ROC curve of the test data set, and yellow represents the ROC curve of the independent validation data set. Figure S14. Alteration in α-diversity and β-diversity within 19 OTUs. (A) PCoA plots of 19 OTUs based on Bray–Curtis distance at day 3. (B) Boxplots of α-diversity (richness, Shannon and Simpson index) at day 28. The median of the data is shown. Differences were analyzed by two-way ANOVA based on the Scheirer-Ray-Hare test. ns, not significant; *P <0.05; **P<0.01. Diet means dietary supplementation of L. reuteri or not; group means oral administration of L. reuteri or not.

Additional file 2: Table S1a

. The relative abudance of taxa at phylum and family level in the feces and colostrum. Table S1b. Description of 112 differential species between I5007 and control groups. Table S1c. Global network parameters of 112 differential species. Table S1d. Description of taxa information for each node in I5007 network. Table S1e. Description of taxa information for each node in control network. Table S1f. Description of differential KOs between I5007 and control groups. Table S1g. Description of metabolite modules of serum metabolites under polar ionic mode. Table S1h. PERMANOVA of fecal microbiota in piglets at different age. Table S1i. Description of taxa information for 19 microbial biomarkers.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, G., Wang, X., Ma, Y. et al. Lactobacillus reuteri improves the development and maturation of fecal microbiota in piglets through mother-to-infant microbe and metabolite vertical transmission. Microbiome 10, 211 (2022). https://doi.org/10.1186/s40168-022-01336-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40168-022-01336-6

Keywords

Microbiome

ISSN: 2049-2618

Contact us